Smart mRNA drugs listen to the body, adjusting protein production based on disease-related signals
Favicon 
phys.org

Smart mRNA drugs listen to the body, adjusting protein production based on disease-related signals

A research team from The University of Osaka and the Institute of Science Tokyo has developed a class of mRNA medicines that can sense changes in the body and autonomously adjust their therapeutic effect. This innovation paves the way for precision treatments that are not only more effective, but also safer—by producing just the right amount of medicine based on real-time biological signals. The research is published in the journal NPG Asia Materials.